Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.130
-0.030 (-2.59%)
Nov 11, 2025, 12:37 PM EST - Market open

Werewolf Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
556614063328-
Upgrade
Market Cap Growth
-63.09%-52.79%121.66%-80.81%--
Upgrade
Enterprise Value
27-2062-62160-
Upgrade
Last Close Price
1.161.483.862.0511.91-
Upgrade
PS Ratio
-34.997.013.84--
Upgrade
PB Ratio
1.850.901.250.522.15-
Upgrade
P/TBV Ratio
1.880.901.250.522.15-
Upgrade
EV/Sales Ratio
--3.10---
Upgrade
Debt / Equity Ratio
1.260.510.470.120.100.03
Upgrade
Asset Turnover
-0.010.120.10--
Upgrade
Quick Ratio
3.737.317.005.6813.2717.52
Upgrade
Current Ratio
3.877.457.145.8413.5717.58
Upgrade
Return on Equity (ROE)
-122.43%-76.33%-31.98%-39.12%-41.31%-30.39%
Upgrade
Return on Assets (ROA)
-40.75%-30.48%-15.11%-20.64%-22.71%-23.72%
Upgrade
Return on Capital (ROIC)
-46.36%-33.60%-16.86%-22.94%-24.06%-26.76%
Upgrade
Earnings Yield
-130.99%-106.92%-26.75%-85.38%-15.22%-
Upgrade
FCF Yield
-114.45%-85.58%-23.89%-70.14%-13.21%-
Upgrade
Buyback Yield / Dilution
-8.89%-23.04%-23.50%-56.40%-1736.32%-57.27%
Upgrade
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q